OBJECTIVE Cannabidiol (CBD) and Δ9-tetrahydrocannabivarin (THCV) are nonpsychoactive phytocannabinoids affecting lipid and glucose metabolism in animal models. This study set out to examine the effects of these compounds in patients with type 2 diabetes.
- 5040 Corporate Plaza Drive, Suite 7R, Colorado Springs, CO 80919
- 719-347-5400
- info@realmofcaring.org